Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ADPGK (EC 184.108.40.206) catalyzes the ADP-dependent phosphorylation of glucose to glucose-6-phosphate and may play a role in glycolysis, possibly during ischemic conditions (Ronimus and Morgan, 2004 [PubMed 14975750]).[supplied by OMIM, Mar 2008].. Additionally we are shipping ADPGK Proteins (6) and ADPGK Kits (4) and many more products for this protein.
Showing 10 out of 41 products:
Human Monoclonal ADPGK Primary Antibody for WB - ABIN393388
Rose, Behm, Drgon, Johnson, Uhl: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. in Molecular medicine (Cambridge, Mass.) 2010
Show all 5 references for ABIN393388
Dog (Canine) Polyclonal ADPGK Primary Antibody for WB - ABIN2778374
Lim, Hao, Shaw, Patel, Szabó, Rual, Fisk, Li, Smolyar, Hill, Barabási, Vidal, Zoghbi: A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. in Cell 2006
Human Monoclonal ADPGK Primary Antibody for RNAi, ELISA - ABIN566495
Richter, Richter, Mehta, Gribble, Sutherland-Smith, Stowell, Print, Ronimus, Wilson: Expression and role in glycolysis of human ADP-dependent glucokinase. in Molecular and cellular biochemistry 2012
ADPGK is substrate inhibited by high glucose concentration and shows high specificity for glucose, with no activity for other sugars, as determined by NMR spectroscopy, including 2-deoxyglucose
ADPGK can contribute to tumour cell survival under conditions of high glycolytic dependence.
human ADPGK(ADP-dependent glucokinase) catalyses ADP-dependent phosphorylation of glucose in vitro, but despite its high expression in human tumour cell lines it appears not to make a quantifiable contribution to glycolysis under the conditions evaluated.
Glucose and insulin (show INS Antibodies) response to oral glucose is higher in GCK (show GCK Antibodies)(261) carriers, indicating clinical heterogeneity in GCK (show GCK Antibodies) maturity diabetes carriers.
The presence of mild persistent hyperglycemia in any patient without autoantibodies should lead to genetic analysis of glucokinase (show GCK Antibodies), particularly if there is a positive family history.
Results suggest that sterol regulatory-element binding protein (show CNBP Antibodies)-1c is unlikely to be the mediator of the early insulin (show INS Antibodies) effect on glucokinase (show GCK Antibodies) gene transcription.
ADPGK (EC 220.127.116.11) catalyzes the ADP-dependent phosphorylation of glucose to glucose-6-phosphate and may play a role in glycolysis, possibly during ischemic conditions (Ronimus and Morgan, 2004
, ADP-dependent glucokinase